Lantern Pharma
LTRN • NASDAQ
Lantern Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Panna Sharma, with a market cap of $12.5M.
CEOPanna Sharma
Next Earnings
Upcoming earnings announcement for Lantern Pharma
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Lantern Pharma
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.39Est: -$0.46 | +15.2% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.40Est: -$0.50 | +20.0% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.42Est: -$0.49 | +14.3% | — | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.54Est: -$0.51 | -5.9% | - | — | 10-K/A |
| Nov 7, 2024 | Q3 2024 | -$0.42Est: -$0.56 | +25.0% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.46Est: -$0.55 | +16.4% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.51Est: -$0.43 | -18.6% | - | — | 10-Q |
| Mar 18, 2024 | Q4 2023 | -$0.39Est: -$0.40 | +2.5% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.29Est: -$0.45 | +35.6% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.44Est: -$0.43 | -2.3% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.36Est: -$0.48 | +25.0% | - | — | — |